Journal
BRAZILIAN JOURNAL OF MICROBIOLOGY
Volume 53, Issue 3, Pages 1101-1113Publisher
SPRINGER
DOI: 10.1007/s42770-022-00739-9
Keywords
Echinocandins; Susceptibility; Biofilms; Antimicrobial/antifungal peptides; beta-1,3-glucan
Categories
Ask authors/readers for more resources
This review summarizes the inhibitory action of Caspofungin on Candida albicans, including its effect on 1,3-beta-D-glucan synthesis, cell wall structure, and biofilm formation. The increasing prevalence of infections caused by non-albicans Candida species and the development of echinocandin resistance pose public health concerns.
Caspofungin and other echinocandins have been used for the treatment of human infections by the opportunistic yeast pathogen, Candida albicans. There has been an increase in infections by non-albicans Candida species such as Candida glabrata, Candida parapsilosis, Candida tropicalis, Candida krusei, and Candida auris in clinical or hospital settings. This is problematic to public health due to the increasing prevalence of echinocandin resistant species/strains. This review will present a summary on various studies that investigated the inhibitory action of caspofungin on 1,3-beta-D-glucan synthesis, on cell wall structure, and biofilm formation of C. albicans. It will highlight some of the issues linked to caspofungin resistance or reduced caspofungin sensitivity in various Candida species and the potential benefits of antimicrobial peptides and other compounds in synergy with caspofungin.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available